319 related articles for article (PubMed ID: 22325689)
21. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
22. Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients.
Ferreira AG; Leão RS; Carvalho-Assef AP; da Silva ÉA; Firmida Mde C; Folescu TW; Paixão VA; Santana MA; de Abreu e Silva FA; Barth AL; Marques EA
APMIS; 2015 Dec; 123(12):1061-8. PubMed ID: 26522829
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
[No Abstract] [Full Text] [Related]
24. Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.
Ho SA; Lee TW; Denton M; Conway SP; Brownlee KG
J Cyst Fibros; 2009 Jan; 8(1):43-6. PubMed ID: 18829398
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
26. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
[No Abstract] [Full Text] [Related]
27. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
Stefani S; Campana S; Cariani L; Carnovale V; Colombo C; Lleo MM; Iula VD; Minicucci L; Morelli P; Pizzamiglio G; Taccetti G
Int J Med Microbiol; 2017 Sep; 307(6):353-362. PubMed ID: 28754426
[TBL] [Abstract][Full Text] [Related]
28. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
29. In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients.
VanDevanter DR; Van Dalfsen JM; Burns JL; Mayer-Hamblett N
J Pediatric Infect Dis Soc; 2015 Jun; 4(2):151-4. PubMed ID: 26407415
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation.
Drenkard E; Ausubel FM
Nature; 2002 Apr; 416(6882):740-3. PubMed ID: 11961556
[TBL] [Abstract][Full Text] [Related]
31. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
32. Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa.
Aaron SD; Ramotar K; Ferris W; Vandemheen K; Saginur R; Tullis E; Haase D; Kottachchi D; St Denis M; Chan F
Am J Respir Crit Care Med; 2004 Apr; 169(7):811-5. PubMed ID: 14670805
[TBL] [Abstract][Full Text] [Related]
33. Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis.
Ali H; Orchard C; Mariveles M; Scott S; Alshafi K; Bilton D; Simmonds N
Eur Respir J; 2015 Sep; 46(3):862-5. PubMed ID: 25882803
[No Abstract] [Full Text] [Related]
34. Acquired resistance to macrolides in
Mustafa MH; Khandekar S; Tunney MM; Elborn JS; Kahl BC; Denis O; Plésiat P; Traore H; Tulkens PM; Vanderbist F; Van Bambeke F
Eur Respir J; 2017 May; 49(5):. PubMed ID: 28526799
[TBL] [Abstract][Full Text] [Related]
35. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Ciofu O; Giwercman B; Pedersen SS; Høiby N
APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
[TBL] [Abstract][Full Text] [Related]
36. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure.
Hayes D; Kanga JF; Anstead MI; Kuhn RJ
Pediatr Pulmonol; 2008 May; 43(5):511-3. PubMed ID: 18383117
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
38. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.
Emerson J; McNamara S; Buccat AM; Worrell K; Burns JL
Pediatr Pulmonol; 2010 Apr; 45(4):363-70. PubMed ID: 20232473
[TBL] [Abstract][Full Text] [Related]
39. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
40. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
